Evaluating the Impact of Cladribine Tablets on the Development of Antibody Titres: Interim Results from the CLOCK-MS Influenza Vaccine Sub-Study

Authors
Category Primary study
ConferenceMultiple Sclerosis Journal
Year 2021
This article has no abstract
Epistemonikos ID: 28a4ab8f57dfdb247d7ec8558c8980970df2cfa0
First added on: Apr 30, 2026